Goldman Sachs Group Inc Elanco Animal Health Inc Call Options Transaction History
Goldman Sachs Group Inc
- $605 Billion
- Q3 2024
Call Options
2 transactions
Others Institutions Holding ELAN
# of Institutions
438Shares Held
473MCall Options Held
4.62MPut Options Held
753K-
Dodge & Cox San Francisco, CA83.3MShares$1.03 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA52.6MShares$653 Million0.58% of portfolio
-
Vanguard Group Inc Valley Forge, PA48.9MShares$608 Million0.01% of portfolio
-
Black Rock Inc. New York, NY23.3MShares$289 Million0.01% of portfolio
-
Black Creek Investment Management Inc. Toronto, A621.3MShares$265 Million11.09% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $5.89B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...